Lupin plans to expand collaboration in other strategic therapeutics areas such as cardio- metabolic, central nervous system and gastro-enterology
Indian firm Lupin has entered into a strategic partnership with Yabao Pharmaceutical Co to meet the growing demand for quality drugs with paediatric formulations in the Chinese markets.
The demand for high quality paediatric medicines has been growing rapidly in China as a result of the government
